These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 15652293

  • 1. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.
    Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293
    [Abstract] [Full Text] [Related]

  • 2. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A, Tonello F, Garofolo G, Muraro L, Carattoli A, Adone R, Montecucco C.
    Vaccine; 2008 Oct 23; 26(45):5684-8. PubMed ID: 18775462
    [Abstract] [Full Text] [Related]

  • 3. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
    Little SF, Ivins BE, Webster WM, Fellows PF, Pitt ML, Norris SL, Andrews GP.
    Vaccine; 2006 Mar 24; 24(14):2530-6. PubMed ID: 16417950
    [Abstract] [Full Text] [Related]

  • 4. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM.
    Vaccine; 2004 Nov 15; 23(1):43-7. PubMed ID: 15519706
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 15; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A, Midha S, Bhatnagar R.
    Biotechnol J; 2009 Mar 15; 4(3):391-9. PubMed ID: 19296443
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 15. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.
    Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG.
    J Infect Dis; 2005 Jan 15; 191(2):278-88. PubMed ID: 15609239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR, Cui Z.
    J Pharm Pharmacol; 2006 Apr 15; 58(4):439-47. PubMed ID: 16597361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.